Abstract:The nuclear receptor family member constitutive activated receptor (CAR) is activated by structurally diverse drugs and environmentally-relevant chemicals leading to transcriptional regulation of genes involved in xenobiotic metabolism and transport. Chronic activation of CAR increases liver cancer incidence in rodents, whereas suppression of CAR can lead to steatosis and insulin insensitivity. Here, analytical methods were developed to screen for chemical treatments in a gene expression compendium that lead to alteration of CAR activity. A gene expression biomarker signature of 83 CAR-dependent genes was identified using microarray profiles from the livers of wild-type and CAR-null mice after exposure to three structurally-diverse CAR activators (CITCO, phenobarbital, TCPOBOP). A rank-based algorithm (Running Fisher's algorithm (p-value ≤ 10(-4))) was used to evaluate the similarity between the CAR biomarker signature and a test set of 28 and 32 comparisons positive or negative, respectively, for CAR activation; the test resulted in a balanced accuracy of 97%. The biomarker signature was used to identify chemicals that activate or suppress CAR in an annotated mouse liver/primary hepatocyte gene expression database of ~1850 comparisons. CAR was activated by 1) activators of the aryl hydrocarbon receptor (AhR) in wild-type but not AhR-null mice, 2) pregnane X receptor (PXR) activators in wild-type and to lesser extents in PXR-null mice, and 3) activators of PPARα in wild-type and PPARα-null mice. CAR was consistently activated by five conazole fungicides and four perfluorinated compounds. Comparison of effects in wild-type and CAR-null mice showed that the fungicide propiconazole increased liver weight and hepatocyte proliferation in a CAR-dependent manner, whereas the perfluorinated compound perfluorooctanoic acid (PFOA) increased these endpoints in a CAR-independent manner. A number of compounds suppressed CAR coincident with increases in markers of inflammation including acetaminophen, concanavalin A, lipopolysaccharide, and 300 nm silica particles. In conclusion, we have shown that a CAR biomarker signature coupled with a rank-based similarity method accurately predicts CAR activation. This analytical approach, when applied to a gene expression compendium, increased the universe of known chemicals that directly or indirectly activate CAR, highlighting the promiscuous nature of CAR activation and signaling through activation of other xenobiotic-activated receptors.

Widespread Epigenetic Changes to the Enhancer Landscape of Mouse Liver Induced by a Specific Xenobiotic Agonist Ligand of the Nuclear Receptor CAR

Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: Primary and secondary gene responses with links to disease progression

Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium

Induction Of Nuclear Translocation Of Constitutive Androstane Receptor By Peroxisome Proliferator-Activated Receptor Alpha Synthetic Ligands In Mouse Liver

Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells

Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches

Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes

Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotion.

Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine

The Role of Constitutive Androstane Receptor in Oxazaphosphorine-Mediated Induction of Drug-Metabolizing Enzymes in Human Hepatocytes

Gadd45b is Required in Part for the Anti-Obesity Effect of Constitutive Androstane Receptor (CAR)

Peroxisome Proliferator-Activated Receptor (Ppar)-Binding Protein (PBP) but Not PPAR-interacting Protein (PRIP) is Required for Nuclear Translocation of Constitutive Androstane Receptor in Mouse Liver.

The CAR Agonist TCPOBOP Inhibits Lipogenesis and Promotes Fibrosis in the Mammary Gland of Adolescent Female Mice

Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way

Constitutive Androstane Receptor Agonist, TCPOBOP: Maternal Exposure Impairs the Growth and Development of Female Offspring in Mice

Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice

Constitutive androstane receptor (CAR) mediates pyrene‐induced mice liver inflammatory response with increased serum amyloid A proteins and Th17 cells

Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation

A Functional Cross-Talk Between Liver X Receptor-Alpha And Constitutive Androstane Receptor Links Lipogenesis And Xenobiotic Responses

Regulatory Mechanics of Constitutive Androstane Receptors: Basal and Ligand-Directed Actions

Transcription Factor-Mediated Regulation Of Carboxylesterase Enzymes In Livers Of Mice